|Day Low/High||1.80 / 1.87|
|52 Wk Low/High||1.53 / 4.75|
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AGM, CETV, CUBI, DVCR, EC, EOCC, ERI, EVA, FBC, GLPG, HCCI, IGT, LII, LXFR, MSL, RXN, TBK, TEGP, USDP, VIRT, VOXX, WNEB Downgrades: ACY, ATNI, BH, BXP, CREE, CYRN, DISCK, EQR, ESSA, GE, HF, SHLO, SMRT, SSBI, UPLD Initiations: BLBD, GEN, MDGS Read on to get TheStreet Quant Ratings' detailed report:
Walk to End Alzheimer's is Largest Fundraiser Dedicated to Alzheimer's Care, Support and Research Programs
Investors considering a purchase of Genesis Healthcare Inc stock, but tentative about paying the going market price of $3.33/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $2.50 strike, which has a bid at the time of this writing of 15 cents.
Important Clinical Collaboration between Genesis HealthCare and UNM Health System
News of Intesa's potential takeover bid extended Generali's three-day gains to 15%.
Paul Bach Named Successor Chief Operating Officer
In recent trading, shares of Genesis Healthcare Inc have crossed above the average analyst 12-month target price of $2.67, changing hands for $2.72/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.